Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Short-term Investments (2024 - 2025)

Historic Short-term Investments for Praxis Precision Medicines (PRAX) over the last 2 years, with Q3 2025 value amounting to $117.6 million.

  • Praxis Precision Medicines' Short-term Investments fell 3755.94% to $117.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.6 million, marking a year-over-year decrease of 3755.94%. This contributed to the annual value of $177.2 million for FY2024, which is N/A changed from last year.
  • Per Praxis Precision Medicines' latest filing, its Short-term Investments stood at $117.6 million for Q3 2025, which was down 3755.94% from $143.9 million recorded in Q2 2025.
  • Praxis Precision Medicines' 5-year Short-term Investments high stood at $206.7 million for Q2 2024, and its period low was $55.4 million during Q1 2024.